Literature DB >> 17591437

Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer.

K Harrington1, P Jankowska, M Hingorani.   

Abstract

Recent advances in our understanding of the biology of cancer have provided enormous opportunities for the development of novel therapies against specific molecular targets. It is likely that most of these targeted therapies will have only modest single agent activities but may have the potential to accentuate the therapeutic effects of ionising radiation. In this introductory review, the 5Rs of classical radiobiology are interpreted in terms of their relationship to the hallmarks of cancer. Future articles will focus on the specific hallmarks of cancer and will highlight the opportunities that exist for designing new combination treatment regimens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591437     DOI: 10.1016/j.clon.2007.04.009

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  16 in total

1.  Molecular biology: the key to personalised treatment in radiation oncology?

Authors:  D G Hirst; T Robson
Journal:  Br J Radiol       Date:  2010-09       Impact factor: 3.039

2.  Enhanced cellular radiosensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity.

Authors:  Jyh-Der Leu; Yu-Wen Chiu; Chia-Chien Lo; Pei-Hsun Chiang; Shu-Jun Chiu; Cheng-Han Tsai; Jeng-Jong Hwang; Ran-Chou Chen; Vera Gorbunova; Yi-Jang Lee
Journal:  Int J Radiat Biol       Date:  2013-03-19       Impact factor: 2.694

3.  Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  J M Del Campo; R Hitt; P Sebastian; C Carracedo; D Lokanatha; J Bourhis; S Temam; D Cupissol; D De Raucourt; N Maroudias; C M Nutting; N Compton; D Midwinter; L Downie; N Biswas-Baldwin; I El-Hariry; K J Harrington
Journal:  Br J Cancer       Date:  2011-08-09       Impact factor: 7.640

4.  Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.

Authors:  Marie Grøn Saelen; Kjersti Flatmark; Sigurd Folkvord; Rik de Wijn; Heidi Rasmussen; Øystein Fodstad; Anne Hansen Ree
Journal:  Angiogenesis       Date:  2011-08-11       Impact factor: 9.596

5.  Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study.

Authors:  Liam Welsh; Rafal Panek; Dualta McQuaid; Alex Dunlop; Maria Schmidt; Angela Riddell; Dow-Mu Koh; Simon Doran; Iain Murray; Yong Du; Sue Chua; Vibeke Hansen; Kee H Wong; Jamie Dean; Sarah Gulliford; Shreerang Bhide; Martin O Leach; Christopher Nutting; Kevin Harrington; Kate Newbold
Journal:  Radiat Oncol       Date:  2015-05-15       Impact factor: 3.481

Review 6.  Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure.

Authors:  Chang-Deng Hu; Richard Choo; Jiaoti Huang
Journal:  Front Oncol       Date:  2015-04-14       Impact factor: 6.244

Review 7.  Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.

Authors:  K J Harrington; L J Billingham; T B Brunner; N G Burnet; C S Chan; P Hoskin; R I Mackay; T S Maughan; J Macdougall; W G McKenna; C M Nutting; A Oliver; R Plummer; I J Stratford; T Illidge
Journal:  Br J Cancer       Date:  2011-07-19       Impact factor: 7.640

Review 8.  Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.

Authors:  Sara Alcorn; Amanda J Walker; Nishant Gandhi; Amol Narang; Aaron T Wild; Russell K Hales; Joseph M Herman; Danny Y Song; Theodore L Deweese; Emmanuel S Antonarakis; Phuoc T Tran
Journal:  Int J Mol Sci       Date:  2013-07-16       Impact factor: 5.923

9.  Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma.

Authors:  Gang Peng; Rubo Cao; Jun Xue; Pindong Li; Zhenwei Zou; Jing Huang; Qian Ding
Journal:  Radiol Oncol       Date:  2014-01-22       Impact factor: 2.991

10.  Cofilin-1 and phosphoglycerate kinase 1 as promising indicators for glioma radiosensibility and prognosis.

Authors:  Wenbo Sun; Hua Yan; Chunfa Qian; Chenhan Wang; Mengjie Zhao; Yuchi Liu; Yujie Zhong; Hongyi Liu; Hong Xiao
Journal:  Oncotarget       Date:  2017-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.